Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases
- PMID: 15088316
Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases
Abstract
Objective: We describe 4 patients who developed subacute cutaneous lupus erythematosus (SCLE)-like photodistributed eruptions after ingestion of docetaxel (Taxotere). The development of SCLE-like cutaneous eruptions has been associated with the intake of drugs including thiazide diuretics, calcium channel blockers, angiotensin converting-enzyme inhibitors, phenytoin, etanercept, antihistaminics, interferons, statins, and terbinafine. Docetaxel, a chemotherapeutic drug used in breast cancer therapy, has not to our knowledge been reported to cause SCLE.
Methods: Skin biopsies were obtained from 4 patients with photodistributed rashes while taking docetaxel.
Results: In all patients, skin biopsies were remarkable for an atrophying interface dermatitis associated with mucin deposition. Immunofluorescent testing revealed the characteristic pattern of SCLE, namely, granular epidermal keratinocyte deposition of IgG and C5b-9. The eruptions resolved following cessation of the drug.
Conclusion: Pathogenetically, docetaxel may evoke a lupus-like eruption through its proapoptotic effects on replicating cells, which could in turn provoke the release of nucleosomes postulated to be target antigens in LE. It seems reasonable to postulate that the rapidly replicating keratinocyte, when subjected to the cytotoxic effects of docetaxel, would also manifest nucleosome release followed by a local autoimmune reaction in a genetically predisposed host.
Similar articles
-
Mixed connective tissue disease. A clinical, histologic, and immunofluorescence study of eight cases.Am J Dermatopathol. 1997 Jun;19(3):206-13. doi: 10.1097/00000372-199706000-00002. Am J Dermatopathol. 1997. PMID: 9185904
-
Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy.Arch Dermatol. 2010 Oct;146(10):1113-6. doi: 10.1001/archdermatol.2010.258. Arch Dermatol. 2010. PMID: 20956642
-
Drug-induced lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17. Arch Dermatol Res. 2009. PMID: 18797892 Review.
-
Taxane associated subacute cutaneous lupus erythematosus.Dermatol Online J. 2013 Aug 15;19(8):19259. Dermatol Online J. 2013. PMID: 24021438
-
Drug-induced lupus: an update on its dermatologic aspects.Lupus. 2009 Oct;18(11):935-40. doi: 10.1177/0961203309106176. Lupus. 2009. PMID: 19762393 Review.
Cited by
-
Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.BMC Neurol. 2023 Apr 26;23(1):168. doi: 10.1186/s12883-023-03146-1. BMC Neurol. 2023. PMID: 37101279 Free PMC article. Review.
-
Subacute cutaneous lupus erythematosus induced by gemcitabine in 2 patients with pancreatic cancer.JAAD Case Rep. 2019 Jun 26;5(7):596-601. doi: 10.1016/j.jdcr.2019.04.020. eCollection 2019 Jul. JAAD Case Rep. 2019. PMID: 31317065 Free PMC article. No abstract available.
-
Drug-induced lupus erythematosus: an update on drugs and mechanisms.Curr Opin Rheumatol. 2018 Sep;30(5):490-497. doi: 10.1097/BOR.0000000000000522. Curr Opin Rheumatol. 2018. PMID: 29870500 Free PMC article. Review.
-
Cutaneous Adverse Reactions of Chemotherapy in Cancer Patients: A Clinicoepidemiological Study.Indian J Dermatol. 2018 Jan-Feb;63(1):41-46. doi: 10.4103/ijd.IJD_65_17. Indian J Dermatol. 2018. PMID: 29527024 Free PMC article.
-
Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review.J Adv Res. 2016 Sep;7(5):719-726. doi: 10.1016/j.jare.2016.04.001. Epub 2016 Apr 23. J Adv Res. 2016. PMID: 28275510 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
